The John C. Martin Foundation is a privately-funded non-profit organization in the United States. It was established in 2014 with the goal to facilitate the establishment of sustainable improvement of health care for populations in socially and economically-disadvantaged settings. Our focus is the advancement of control and prevention of endemic illnesses among underserved populations of the world.

The Foundation’s charitable activity takes the form of grantmaking. Funding priority is for local projects that can deliver marked, self-sustaining, self-advancing and long-lasting impact to target communities.

Supported grants include knowledge-building among healthcare providers, disease epidemiologic investigations to better define public health burdens and inform health policy decisions, prevention of transmission of viral infections, and healthcare infrastructure improvement for impoverished populations.

Funding Support Provided to:

Polaris Observatory


Polaris Observatory, founded by the CDA Foundation, is an online database of epidemiological and disease-burden data for hepatitis B and C. Polaris Observatory has become the authoritative resource for epidemiological data, modeling tools, training and decision analytics to support elimination of hepatitis B and C globally by 2030. VISIT SITE

Liver Care Delivery in Northeastern India


Liver Foundation, West Bengal (LFWB) is a not-for-profit organization registered in West Bengal, India. In partnership with the Baptist Christian Hospital in Tezpur in Assam, LFWB implemented a comprehensive care delivery for hepatitis B for the communities in Arunachal Pradesh, highly prevalent in HBV, in the northeastern hill region of India. VISIT SITE

The Indian Institute of Liver and Digestive Sciences (IILDS), an initiative of LFWB, is an emerging healthcare and science center specialized in liver and gastrointestinal diseases. IILDS services the populations in the East and Northeastern regions of India with quality health care regardless of the patients’ ability to pay. VISIT SITE

Integrated Database for Community-Based Hepatitis B Project


Global Virus Network (GVN) is a network of Centers of Excellence and Affiliate institutions worldwide. As a pilot study, GVN has established a clinical database by developing a software application in support of a community-based hepatitis B project in rural Arunachal Pradesh, India. This mobile (tablet-enabled) application is used to collect and transfer data from the field and clinic sites, where data from all sites are synchronized through the Cloud. This tool has the potential to be applicable for clinical projects in a variety of geographies. VISIT SITE

A Web-Based Program to Improve Care for Patients in Argentina


Fundación Icalma is a non-profit organization in Buenos Aires made up of health workers devoted to the care of patients. With the aim to decentralize care from specialists in Buenos Aires to general practitioners in remote areas, Icalma developed a system of tele-consultations and training activities. This program aims to improve the care of patients with liver disease who have limited access to best practices in hepatology. VISIT SITE

Capacity Building of County and Municipal Hospitals on Hepatitis Diagnosis and Treatment in China


Chinese Foundation for Hepatitis Prevention and Control is a public charity organization in Beijing dedicated to reducing incidence and disease burden of hepatitis in China. They designed and implemented a program to improve local capacity at county and municipal levels by means of educational workshop and clinical practice training/case studies, developing routine hepatitis epidemic reporting, and establishing networking between provincial level specialists and local doctors. The first program was completed in two developing provinces, Shanxi and Shaanxi in western China. The program has the potential to be beneficial to other underserved provinces. VISIT SITE

Prevention of Transmission of HBV from Mother to Child


Combined immunoprophylaxis by hepatitis B immune globulin (HBIg) and hepatitis B vaccine at birth is largely effective in protecting infants from HBV infection. However, HBIg is expensive and not available in many developing countries, resulting in approximately 30% of infant infection when they received only hepatitis B vaccination. Recent data show that mother-to-child transmission (MTCT) of HBV can be safely prevented when tenofovir disoproxil fumarate (TDF) is received by highly viremic mothers during the third trimester of pregnancy together with the combined immunoprophylaxis is received by infants at birth. The present study aims to investigate if MTCT can be similarly prevented if highly viremic mothers start TDF treatment at the second trimester together with infants receive HBV vaccination, omitting HBIg, at birth. VISIT SITE

Hepatitis Delta in China


China has the highest HBV infected population in the world, yet the prevalence of HDV infection is largely undefined. Researchers at Beijing Ditan Hospital investigated HDV prevalence across China and found that it appears to vary based on geography and HIV status of the tested individuals. Interestingly, the prevalence of HDV did not match with that of HBV geographically.

Myanmar HIV/TB Medical Forum


The Myanmar Society of HIV Medicine, registered under the Myanmar Medical Association, is a nonprofit nongovernmental organization with the major objectives of promoting quality prevention of HIV infection and care services for HIV infected individuals, and sharing of updated information through academic activities and research. VISIT SITE

Democratizing Healthcare in Kenya Through Mobile Technology


PharmAccess Foundation is a philanthropy organization based in the Netherlands. The organization has innovated and continues to develop several complimenting programs achieving comprehensive improvement of healthcare for Africa including a mobile wallet system (M-Tiba) operated from personal mobile phones where funds in the “wallet” can only be used to pay for health-related services. A pilot program in Kenya is starting to integrate health insurance coverage via the mobile health wallet. This initiative has the promise to transform healthcare in economically-deprived countries beyond Kenya. VISIT SITE

Advancing Global Elimination of Viral Hepatitis


The World Hepatitis Summit (WHS) is a joint initiative between World Health Organization and the World Hepatitis Alliance to advance the movement toward eliminating viral hepatitis globally by involving patient groups, health officials, public health experts and other stakeholders worldwide. In collaboration with the host country for each Summit, the inaugural WHS took place in 2015 in Scotland and the second WHS took place in 2017 in Brazil. VISIT SITE

Together with the World Hepatitis Alliance, regional hepatitis focal points are funded to coordinate hepatitis response in the WHO European and Africa Regions. The regional focus points serve to provide technical support to individual countries, many of which are lacking the necessary technical expertise, to develop a national strategy.

Asian Liver Center at Stanford University Medical Center


The Asian Liver Center at Stanford University is the first non-profit organization in the United States that addresses the disproportionately high rates of chronic hepatitis B infection and liver cancer in Asians and Asian Americans. Through collaboration, research, evidence-based advocacy and education, the Center aims to eliminate transmission and stigma, and reduce death and disease caused by hepatitis B in high prevalence countries. VISIT SITE

The World Indigenous Peoples’ Conference on Viral Hepatitis (WIPCVH) 2017


WIPCVH 2017 is led by Indigenous people and is designed for Indigenous peoples, clinicians, those working in Indigenous health and civil society organizations. The 2017 conference took place in Anchorage, Alaska and was hosted by Alaska Native Tribal Health Consortium. VISIT SITE

EndHep2030, Sponsored Program by the Rockefeller Philanthropy Advisors


A new and the only grant-making organization dedicated exclusively to the mission of ending viral hepatitis in the world. VISIT SITE